Literature DB >> 8406835

Specific serum and local antibody responses against Cryptosporidium parvum during medication of calves with halofuginone lactate.

J E Peeters1, I Villacorta, M Naciri, E Vanopdenbosch.   

Abstract

Fecal and serum anti-Cryptosporidium parvum immunoglobulin A (IgA), IgM, and IgG were monitored by an enzyme immunoassay in C. parvum-infected calves after medication with halofuginone lactate. In a first experiment, four groups of five 1-day-old colostrum-fed calves were inoculated with 10(6) oocysts of C. parvum. They were medicated with 0, 30, 60, or 120 micrograms of halofuginone lactate per kg from days 2 to 8 postinfection (p.i.). Unmedicated calves passed large numbers of oocysts between 3 and 14 days p.i. Treatment with 30 micrograms/kg did not completely inhibit oocyst output during medication, whereas 60 and 120 micrograms/kg did. The latter groups passed only a reduced number of oocysts when the drug was withdrawn. In a second experiment, 3- to 6-day-old colostrum-fed calves were divided into three groups of 16 or 17 animals each. All animals had acquired C. parvum infection before arrival at the fattening unit. They were medicated with 0, 60, or 120 micrograms/kg for 7 days beginning on the day of arrival. Unmedicated calves passed large numbers of oocysts from 0 to 21 days. Medication stopped oocyst output at day 7, but some of the calves again passed low numbers of oocysts 7 days after withdrawal of the drug. Experimental infection of unmedicated calves was followed by a rise in local anti-C. parvum IgA and IgM titers. Rising coproantibody levels coincided with falling oocyst output. In halofuginone-medicated and experimentally infected calves, only specific anti-C. parvum IgM levels rose during the first 5 days p.i. Specific IgA levels increased in association with oocyst output after withdrawal of the drug in the 60- and 120-micrograms/kg groups. In naturally infected calves, on the other hand, both specific IgA and IgM levels rose further during medication. Although titers were lower than in unmedicated controls, no significant differences were observed. Both medicated and unmedicated calves were equally protected from a challenge with 10(7) oocysts 16 weeks after the first contact with the parasite.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406835      PMCID: PMC281177          DOI: 10.1128/iai.61.10.4440-4445.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs.

Authors:  V McDonald; R Stables; D C Warhurst; M R Barer; D A Blewett; H D Chapman; G M Connolly; P L Chiodini; K P McAdam
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

2.  Effectiveness of arprinocid in the reduction of cryptosporidial activity in immunosuppressed rats.

Authors:  J E Rehg; M L Hancock
Journal:  Am J Vet Res       Date:  1990-10       Impact factor: 1.156

3.  Analysis of the kinetics, isotype and specificity of serum and coproantibody in lambs infected with Cryptosporidium parvum.

Authors:  B D Hill; D A Blewett; A M Dawson; S Wright
Journal:  Res Vet Sci       Date:  1990-01       Impact factor: 2.534

4.  Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply.

Authors:  E B Hayes; T D Matte; T R O'Brien; T W McKinley; G S Logsdon; J B Rose; B L Ungar; D M Word; P F Pinsky; M L Cummings
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

5.  Chemotherapeutic effect of arprinocid in experimental cryptosporidiosis.

Authors:  C W Kim
Journal:  J Parasitol       Date:  1987-06       Impact factor: 1.276

6.  A waterborne outbreak of cryptosporidiosis in normal hosts.

Authors:  R G D'Antonio; R E Winn; J P Taylor; T L Gustafson; W L Current; M M Rhodes; G W Gary; R A Zajac
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

7.  Prophylactic effects of anticoccidial drugs in experimental murine cryptosporidiosis.

Authors:  K W Angus; G Hutchison; I Campbell; D R Snodgrass
Journal:  Vet Rec       Date:  1984-02-18       Impact factor: 2.695

8.  Resistance of calves to Cryptosporidium parvum: effects of age and previous exposure.

Authors:  J A Harp; D B Woodmansee; H W Moon
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

9.  Effect of disinfection of drinking water with ozone or chlorine dioxide on survival of Cryptosporidium parvum oocysts.

Authors:  J E Peeters; E A Mazás; W J Masschelein; I Villacorta Martiez de Maturana; E Debacker
Journal:  Appl Environ Microbiol       Date:  1989-06       Impact factor: 4.792

10.  Efficacy of halofuginone lactate against Cryptosporidium parvum in calves.

Authors:  I Villacorta; J E Peeters; E Vanopdenbosch; E Ares-Mazás; H Theys
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

View more
  7 in total

1.  Fecal antibodies to Cryptosporidium parvum in healthy volunteers.

Authors:  S M Dann; P C Okhuysen; B M Salameh; H L DuPont; C L Chappell
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study.

Authors:  R Mancassola; J M Reperant; M Naciri; C Chartier
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

3.  Control of cryptosporidiosis in neonatal calves: use of halofuginone lactate in two different calf rearing systems.

Authors:  V De Waele; N Speybroeck; D Berkvens; G Mulcahy; T M Murphy
Journal:  Prev Vet Med       Date:  2010-08-06       Impact factor: 2.670

Review 4.  A review of the importance of cryptosporidiosis in farm animals.

Authors:  D C de Graaf; E Vanopdenbosch; L M Ortega-Mora; H Abbassi; J E Peeters
Journal:  Int J Parasitol       Date:  1999-08       Impact factor: 3.981

5.  Prevalence and control of bovine cryptosporidiosis in German dairy herds.

Authors:  A Joachim; T Krull; J Schwarzkopf; A Daugschies
Journal:  Vet Parasitol       Date:  2003-03-25       Impact factor: 2.738

6.  Preventive and therapeutic efficacy of halofuginone-lactate against Cryptosporidium parvum in spontaneously infected calves: a centralised, randomised, double-blind, placebo-controlled study.

Authors:  Pavel Klein
Journal:  Vet J       Date:  2007-07-02       Impact factor: 2.688

Review 7.  Pathophysiology of diarrhea in calves.

Authors:  D M Foster; Geof W Smith
Journal:  Vet Clin North Am Food Anim Pract       Date:  2009-03       Impact factor: 3.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.